Analysis Roquefort Therapeutics plc (ROQ)
6/4/2024
Analysis of Roquefort Therapeutics plc (ROQ)
Roquefort Therapeutics plc (ROQ) has shown some interesting price movements recently. The stock closed at 7.50 on the most recent trading day, with a high of 7.50 and a low of 6.75. The Relative Strength Index (RSI) is quite high at 81.23, indicating that the stock may be overbought.Looking at the Moving Average Convergence Divergence (MACD) indicator, the MACD line is above the signal line, with a positive MACD histogram. This suggests a bullish momentum in the stock price.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing an upward trend, indicating a positive price movement.
Overall, based on the RSI, MACD, and moving averages, Roquefort Therapeutics plc seems to be in a bullish phase. However, investors should be cautious of the high RSI value, which could indicate a potential reversal in the short term.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020 and its lowest point in 2022.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in key financial metrics over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. Current assets have fluctuated but generally increased, with the highest value in 2023 at $143.6 billion.
3. Non-current assets have also shown an increasing trend, reaching $209 billion in 2023.
4. Total liabilities have been increasing steadily, from $248 billion in 2019 to $290.4 billion in 2023.
5. Shareholders' equity has shown some fluctuations but has increased overall, from $90.5 billion in 2018 to $62.1 billion in 2023.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes information on the financials, stock statistics, valuations metrics, stock price summary, and dividends and splits for a specific company. Here is a summary of the key data points:1. Financials:
- Cash Flow: Operating cash flow (TTM) is $110,563,000,320 and levered free cash flow (TTM) is $84,726,874,112.
- Balance Sheet: Total cash (MRQ) is $67,150,000,128, total debt (MRQ) is $104,590,000,128, current ratio (MRQ) is 1.037, book value per share (MRQ) is $4.837, total cash per share (MRQ) is $4.379, and total debt to equity ratio (MRQ) is 140.968.
- Profit Margin: 26.306%
- Income Statement: EBITDA is $131,393,000,000, revenue (TTM) is $381,623,009,280, diluted EPS (TTM) is $6.43, gross profit (TTM) is $169,148,000,000, revenue per share (TTM) is $24.537, net income to common (TTM) is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Return on Assets (TTM): 22.073%
- Return on Equity (TTM): 147.25%
2. Stock Statistics:
- Short Ratio: 1.53
- Float Shares: 15,308,320,742
- Shares Short: 99,287,450
- Average 10-Day Volume: 46,860,048
- Average 90-Day Volume: 57,498,254
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.589%
- Short Percent of Shares Outstanding: 0.65%
3. Valuations Metrics:
- PEG Ratio: 26.319502
- Forward P/E: 26.319502
- Trailing P/E: 29.59409
- Enterprise Value: $2,950,762,332,160
- Price to Book (MRQ): 39.3405
- Price to Sales (TTM): 7.646095
- Enterprise to EBITDA: 22.763
- Enterprise to Revenue: 7.732
- Market Capitalization: $2,917,925,650,432
4. Stock Price Summary:
- Beta: 1.264
- 50-Day Moving Average: $176.2646
- 200-Day Moving Average: $181.0429
- 52-Week Low: $164.08
- 52-Week High: $199.62
- 52-Week Change: 6.853%
5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.5255%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.5097%
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023, showing a healthy growth trajectory.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trend.
7. The company has been able to maintain a healthy EBITDA margin over the years, indicating operational efficiency.
8. Overall, the financial performance of the company in terms of revenue generation has been positive, with steady growth in sales and profitability.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a growth trajectory from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing a trend of expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate is expected to increase further to 9.7% in the next year.
5. Past 5 Years: Over the past 5 years, the company has shown an average annual growth rate of 20.1%.
6. Next 5 Years: Looking ahead, analysts project an average annual growth rate of 9.7% for the next 5 years.
Overall, the company is expected to maintain a steady growth trajectory, with a slight increase in growth rates for the upcoming periods compared to the current ones. However, the projected growth rates are lower than the average growth rate observed over the past 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164, the high end at $275, and the average at $204.58. The current price of the security is $192.25, which is below the median and average forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.
MACD of ROQ
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
